| Basics |
Bruker Corporation Common Stock
Bruker Corp is a developer, manufacturer and distributor of scientific instruments and analytical and dignostic solutions that enable customers to explore life and materials at microscopic, molecular and cellular levels.
|
| IPO Date: |
July 2, 2003 |
| Sector: |
Healthcare |
| Industry: |
Life Sciences Tools and Services |
| Market Cap: |
$7.47B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.42 | 1.67%
|
| Avg Daily Range (30 D): |
$0.82 | 1.70%
|
| Avg Daily Range (90 D): |
$0.83 | 2.07%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.67M |
| Avg Daily Volume (30 D): |
1.84M |
| Avg Daily Volume (90 D): |
2.49M |
| Trade Size |
| Avg Trade Size (Sh.): |
93 |
| Avg Trade Size (Sh.) (30 D): |
63 |
| Avg Trade Size (Sh.) (90 D): |
69 |
| Institutional Trades |
| Total Inst.Trades: |
9,941 |
| Avg Inst. Trade: |
$2.71M |
| Avg Inst. Trade (30 D): |
$3.78M |
| Avg Inst. Trade (90 D): |
$3.94M |
| Avg Inst. Trade Volume: |
.07M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.05M |
| Avg Closing Trade (30 D): |
$15.18M |
| Avg Closing Trade (90 D): |
$14.53M |
| Avg Closing Volume: |
107.47K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
|
$-.41
|
$.05
|
|
Diluted EPS
|
|
$-.41
|
$.05
|
|
Revenue
|
$
|
$ 860.5M
|
$ 797.4M
|
|
Gross Profit
|
$
|
$ 379.4M
|
$ 357.9M
|
|
Net Income / Loss
|
$
|
$ -58.5M
|
$ 4.2M
|
|
Operating Income / Loss
|
$
|
$ -51.8M
|
$ 11.9M
|
|
Cost of Revenue
|
$
|
$ 481.1M
|
$ 439.5M
|
|
Net Cash Flow
|
$
|
$ 201.1M
|
$ -91.5M
|
|
PE Ratio
|
|
|
|
|
|
|
